Funding boost provides TB scientist with vital equipment

Centenary Institute - Dr Elinor Hortle


A young Centenary scientist looking into new ways to treat the world’s deadliest infectious disease, tuberculosis, has used a $10,000 funding award to invest in a critical piece of equipment.

Dr Elinor Hortle was among three Centenary scientists to take home top prizes at the 2018 Sydney LHD Innovation and Research Awards in June.

Dr Hortle won the Annual Health Research Infrastructure Award, which provides a high-achieving early-career scientist with funding to purchase, maintain or hire equipment associated with a basic science research project.

As part of the Immune-Vascular Interactions Laboratory, Dr Hortle has used the funding to purchase a micro-injector; a machine which is able to inject very small amounts of substance (about 2nl, or 0.000002 ml per injection).

Dr Hortle says the micro-injector is critical to her research.

“My research relies almost entirely on genetically modified fish – so that’s fish either expressing fluorescent proteins in particular cell types, or fish that have had genes that we’re interested in turned off.

“To make these genetically-modified fish, we have to inject DNA or RNA into the single-cell stage of the embryo. A single cell is very tiny, hence the need for a micro-injector.”

Latest News

Run the City2Surf with Team Centenary

Come run with us and help support our ground-breaking medical research.

Soiree with the Scientists

The Centenary Institute was delighted to host one of its signature supporter events, Soiree with the Scientists.

Get Voting for People’s Choice Award

Who should be named the ‘People’s Choice’ winner of the 2019 Centenary Institute Medical Innovation Awards?


News Topics